Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 158

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 158
---
ortized cost of $33,682)

    33,660

    —

    Restricted cash

    2,897

    2,932

    Intangible assets, net

    3,425

    5,128

    Goodwill

    118,972

    118,972

    Other assets

    2,287

    3,591

    Total assets
     
    $
    539,376

    $
    661,134

    Liabilities and shareholders’ equity

    Current liabilities

    Accounts payable
     
    $
    7,265

    $
    7,719

    Accrued liabilities

    8,157

    8,597

    Accrued compensation and benefits

    15,838

    13,685

    Current portion of operating lease liabilities

    10,239

    9,384

    Current portion of deferred revenue

    55,689

    48,630

    Current portion of revenue interest liability, net

    865

    —

    Total current liabilities

    98,053

    88,015

    Long-term liabilities

    Operating lease liabilities, less current portion

    79,148

    89,388

    Deferred revenue, less current portion

    27,256

    44,793

    Revenue interest liability, net, less current portion

    132,414

    130,660

    Other long-term liabilities

    20

    —

    Total liabilities

    336,891

    352,856

    Commitments and contingencies (Note 12)

    Shareholders’ equity

    Preferred stock: $0.0001 par value, 10,000,000 shares authorized at December 31, 2024 and 2023; no shares issued and outstanding at December 31, 2024 and 2023

    —

    —

    Common stock: $0.0001 par value, 340,000,000 shares authorized at December 31, 2024 and 2023; 147,773,744 and 145,082,271 shares issued and outstanding at December 31, 2024 and 2023, respectively

    14

    14

    Additional paid-in capital

    1,506,353